175 related articles for article (PubMed ID: 15725048)
21. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
22. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.
Weiss K; Vanjaka A;
Clin Ther; 2002 Dec; 24(12):2105-22. PubMed ID: 12581548
[TBL] [Abstract][Full Text] [Related]
23. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis].
Perronne C; Drugeon H; Zuck P; Filipecki J; Vincent-Lacaze N; Goldfarb G; Léophonte P
Med Mal Infect; 2005 Oct; 35(10):507-15. PubMed ID: 16239090
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
Quinn J; Ruoff GE; Ziter PS
Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
[TBL] [Abstract][Full Text] [Related]
27. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Mathers Dunbar L; Hassman J; Tellier G
Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
[TBL] [Abstract][Full Text] [Related]
30. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.
Hoeffken G; Meyer HP; Winter J; Verhoef L;
Respir Med; 2001 Jul; 95(7):553-64. PubMed ID: 11453311
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
33. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
Drehobl MA; De Salvo MC; Lewis DE; Breen JD
Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
[TBL] [Abstract][Full Text] [Related]
34. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
35. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
Darkes MJ; Perry CM
Am J Respir Med; 2003; 2(2):175-201. PubMed ID: 14720016
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Chodosh S; Lakshminarayan S; Swarz H; Breisch S
Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
[TBL] [Abstract][Full Text] [Related]
37. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
[TBL] [Abstract][Full Text] [Related]
38. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
39. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Fisher CL; Busman T; Olson CA
Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
